FDA

Latest Stories

Menthol cigarettes and other tobacco products are displayed at a store in San Francisco on May 17, 2018. The U.S. government is set to release its long-awaited plan to ban menthol cigarettes and flavored cigars. On Thursday, April 28, 2022, Food and Drug Administration Commissioner Robert Califf previewed the announcement in congressional testimony, saying the proposal would reduce disease and death among smokers and help many quit. (AP Photo/Jeff Chiu, File)

White House delays menthol cigarette ban

By Matthew Perrone - Associated Press

A sign for the U.S. Food and Drug Administration is displayed outside their offices in Silver Spring, Md., Dec. 10, 2020. The Indian manufacturer of more than two dozen varieties of eyedrops subject to a U.S. safety warning officially recalled the products, which were sold by CVS Health, Target, Rite Aid and other national retailers. Kilitch Healthcare India issued the recall on Monday, Nov. 13, 2023, and the FDA published the notice Wednesday, Nov 15. (AP Photo/Manuel Balce Ceneta, File)

Indian manufacturer recalls eyedrops previously cited in FDA warning

By Matthew Perrone - Associated Press

Court Ruling Against the FDA and Big Abortion Illustration by Greg Groesch/The Washington Times

Unfettered abortion pill access is exploitation, not liberation

By Chelsey Youman

FILE - This July 2019 image provided by the Sarah Cannon Research Institute shows Victoria Gray on her infusion day during a gene editing trial for sickle cell disease at the Sarah Cannon Research Institute and The Children's Hospital At TriStar Centennial in Nashville. Gray, the first patient to test the treatment, shared her experience with researchers at a scientific conference in 2023. She described suffering with terrible bouts of pain since childhood and receiving high-dose pain medications and sometimes blood transfusions. She described feeling she "was being reborn” the day she got the gene therapy. (Anthem Pictures/Sarah Cannon Research Institute via AP, File)

A new cure for sickle cell disease may be coming. Health advisers will review it next week

By Laura Ungar - Associated Press

FDA Ban on Menthol Cigarettes Illustration by Greg Groesch/The Washington Times

Rethinking the FDA’s menthol ban

By Paris Dennard

A sign marks a CVS branch on Tuesday, May 16, 2023, in Pasadena, Calif. CVS Health is pulling from its drugstore shelves, Friday, Oct. 20, some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers. (AP Photo/Marcio Jose Sanchez, File)

CVS to remove ineffective cold medicines after FDA panel says main ingredient doesn’t work

By Brad Matthews - The Washington Times

Illustration on chemical abortion by Alexander Hunter/The Washington Times

Death by chemical abortion

By Janet Morana

FILE - A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. On Friday, Sept. 29, 2023, the FDA laid out a proposal to begin regulating laboratory medical tests, a multibillion-dollar industry that it says poses a growing risk to patients because of potentially inaccurate results. (AP Photo/Manuel Balce Ceneta, File)

FDA wants to regulate thousands of lab tests that have long skirted oversight

By Matthew Perrone - Associated Press

Alyona Dixon, 24, died of complications from septic abortion on Sept. 28, 2022, after obtaining abortion pills from Planned Parenthood. Her husband Michael Dixon filed a wrongful-death lawsuit on Sept. 14, 2023, against Dignity Health, where she was treated afterward. Photo courtesy Bighorn Law.

Nevada woman’s death after taking abortion pills spurs lawsuit, safety fears

By Valerie Richardson - The Washington Times

Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005. The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient. Advisers to the Food and Drug Administration voted unanimously on Tuesday, Sept. 12, 2023 against the effectiveness of the ingredient found in popular versions of Sudafed, Allegra, Dayquil and other medications sold on pharmacy shelves. (AP Photo, File)

Popular nasal decongestant doesn’t actually relieve congestion, FDA experts say

By Matthew Perrone - Associated Press

Sudafed and other common nasal decongestants containing pseudoephedrine are on display behind the counter at Hospital Discount Pharmacy in Edmond, Okla., Jan. 11, 2005. The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient. Advisers to the Food and Drug Administration voted unanimously on Tuesday, Sept. 12, 2023 against the effectiveness of the ingredient found in popular versions of Sudafed, Allegra, Dayquil and other medications sold on pharmacy shelves. (AP Photo, File)

FDA panel says ingredient in popular oral decongestants is not effective

By Tom Howell Jr. - The Washington Times

Dr. Mandy Cohen, director of the Centers for Disease Control and Prevention, receives a flu vaccine from Nurse Practitioner Whitney Goggans at the Atlanta Press Club, where Cohen spoke about health issues, Wednesday, Sept. 6, 2023, in Atlanta. Cohen says the U.S. is in “our strongest position yet” to avoid another chaotic respiratory season. “There will be a lot of virus this winter. That’s why we want to get ahead of it.” (AP Photo/Mike Stewart, File)

Updated COVID shots are coming. They’re part of a trio of vaccines to block fall viruses

By Lauran Neergaard - Associated Press

A box of ivermectin is shown in a pharmacy as pharmacists work in the background, Thursday, Sept. 9, 2021, in Ga. A federal appeals court Friday, Sept. 1, 2023 revived a lawsuit by three doctors who say the Food and Drug Administration overstepped its authority in a campaign against treating COVID-19 with the anti-parasite drug ivermectin(AP Photo/Mike Stewart, File)

Court revives doctors’ lawsuit saying FDA overstepped its authority with anti-ivermectin campaign

By Kevin McGill - Associated Press

A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on, Oct. 12, 2022. New restrictions on access to the drug used in the most common form of abortion would be imposed under a federal appeals court ruling issued Wednesday, Aug. 16, 2023, but the Supreme Court will have the final say. (AP Photo/Charlie Riedel, File)

Court lets abortion pill stay on market, but not in mail; FDA’s relaxed rules exceed comfort level

By Stephen Dinan and Alex Swoyer - The Washington Times

FILE - A patient prepares to take the first of two combination pills, mifepristone, for a medication abortion during a visit to a clinic in Kansas City, Kan., on, Oct. 12, 2022. New restrictions on access to the drug used in the most common form of abortion would be imposed under a federal appeals court ruling issued Wednesday, Aug. 16, 2023, but the Supreme Court will have the final say. (AP Photo/Charlie Riedel, File)

Some abortion drug restrictions are upheld by an appeals court in a case bound for the Supreme Court

By KEVIN McGILL - Associated Press

A sign for the Food and Drug Administration is displayed outside their offices in Silver Spring, Md., on Dec. 10, 2020. Federal regulators are warning consumers that now-recalled lots of the Tydemy birth control pill “may have reduced effectiveness” due to decreased levels of a key ingredient of the product. Lupin Pharmaceuticals, which manufactures Tydemy, notified customers on Saturday that it was voluntarily recalling two batches of the oral contraceptive — after one lot tested low for ascorbic acid. (AP Photo/Manuel Balce Ceneta, File)

Birth control scare: Hundreds of thousands of pills recalled over fear they don’t work

By Brad Matthews - The Washington Times

This illustration provided by AstraZeneca depicts packaging for their medication Beyfortus. U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on Monday, July 17, 2023 approved the injection for infants and children up to 2 years old. (AstraZeneca via AP)

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

By Matthew Perrone - Associated Press

A sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. (AP Photo/Darron Cummings, File)

Second Alzheimer’s drug in the pipeline promises to slow worsening but with safety concern

By Lauran Neergaard - Associated Press

This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. U.S. officials have approved the first over-the-counter birth control pill, a major change that will broaden access for women and teenagers. The Food and Drug Administration decision on Thursday, July 13, 2023, means drugmaker Perrigo can sell its once-a-day Opill without a prescription. (Perrigo via AP, File)

FDA approves first over-the-counter birth control pill amid pressure over reproductive rights

By Valerie Richardson - The Washington Times

This illustration provided by Perrigo in May 2023, depicts proposed packaging for the company's birth control medication Opill. U.S. officials have approved the first over-the-counter birth control pill, a major change that will broaden access for women and teenagers. The Food and Drug Administration decision on Thursday, July 13, 2023, means drugmaker Perrigo can sell its once-a-day Opill without a prescription. (Perrigo via AP, File)

First over-the-counter birth control pill gets FDA approval

By Matthew Perrone - Associated Press